German Center for Lung Research (DZL) successfully completes investigator-initiated study evaluating SB010 in COPD patients
Marburg, Germany, 11 September 2017
- Results presented today at the European Respiratory Society International Congress 2017 in Milan, Italy
sterna biologicals GmbH & Co. KG ("sterna biologicals") announced today that investigator Dr Timm Greulich from the Department of Medicine, Pulmonary and Critical Care Medicine, Philipps University Marburg, will present key results of the recently completed Phase II clinical trial of SB010 at the European Respiratory Society (ERS) Congress held in Milan, Italy, 9 to 13 September 2017.